Cubist Pharmaceuticals, Inc. (CBST) Focuses on Expanded Antibiotic Pipeline to Combat Infectious Diseases at IDWeek 2013
10/2/2013 6:25:09 AM
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that it will focus on its expanded pipeline of antibiotics, represented through several presentations, during IDWeek 2013 being held October 2-6 in San Francisco. Presentations will feature the company’s development of antibiotics for serious infections caused by multidrug-resistant bacteria. Several presentations will also highlight the marketed antibiotic CUBICIN® (daptomycin for injection).
Help employers find you! Check out all the jobs and post your resume.
comments powered by